Keywords
maternal-fetal exchange
placenta
fatty liver
How to Cite
Abstract
Maternal obesity programs anomalies in fetuses and placentas. Butyrate, a product of fiber metabolism from the intestinal microbiota, improves lipid and glucose homeostasis.
Our aim was to address whether oral administation of butyrate prevents fetal and placental alterations in pregnancy from overweight rats.
Female rats fed a control or fatty diet (FD, 28% of fat) were mated with control males1. Butyrate (3%) or vehicle, was orally delivered daily during gestation. The rats were euthanized at 21 days of gestation, fetuses, fetal livers and placentas were obtained, and weighed. Maternal and fetal plasma was obtained by decapitation.
Butyrate prevented maternal hypertriglyceridemia and macrosomia in FD fetuses (p<0.05). Placentas from FD rats displayed lipid overaccumulation (p<0.05) and an upregulation of mRNA levels of lipoprotein-lipase (LPL) (p<0.05), fatty-acid-binding-protein 5 (p<0.01) and perilipin2 (p<0.05) compared to controls. Butyrate prevented LPL increases only in female placenta. The FD fetuses showed lipid overaccumulation in livers (p<0.01) that was normalized by butyrate (p<0.05).
Oral administration of butyrate prevents the increase in maternal triglyceridemia and partially normalizes the expression of placental lipid transporters. This, in turn, could reduce fetoplacental lipid transport and prevent fetal overgrowth and overaccumulation of liver lipids, clear marker of fetal fatty liver programming.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.